Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose

Rinaldo Bellomo, Johannes Martensson, Serigne Lo, KM Kaukonen, Alan Cass, Martin Gallagher

    Research output: Contribution to journalArticle

    Abstract

    Aims: The study aims to describe the use of dialysis catheters in critically ill patients treated with continuous renal replacement therapy (CRRT) and to study the impact of femoral versus non-femoral access on CRRT dose.


    Methods: Statistical analysis and predictive modelling of data from the Randomized Evaluation of Normal vs. Augmented Level renal replacement therapy trial.


    Results: 
    The femoral vein was the first access site in 937 (67%) of 1,399 patients. These patients had higher Acute Physiology and Chronic Health Evaluation and Sequential Organ Failure Assessment scores (p = 0.009) and lower pH (p < 0.001) but similar mortality to patients with non-femoral access (44 vs. 45%; p = 0.63). Lower body weight was independently associated with femoral access placement (OR 0.97, 95% CI 0.96-0.98). Femoral access was associated with a 1.03% lower CRRT dose (p = 0.05), but a 4.20% higher dose was achieved with 13.5 Fr catheters (p = 0.03).


    Conclusions:
     Femoral access was preferred in lighter and sicker patients. Catheter gauge had greater impact than catheter site in CRRT dose delivery. Video Journal Club "Cappuccino with Claudio Ronco" at http://www.karger.com/?doi=439581.

    Original languageEnglish
    Pages (from-to)11-17
    Number of pages7
    JournalBlood Purification
    Volume41
    Issue number1-3
    DOIs
    Publication statusPublished - Mar 2016

      Fingerprint

    Cite this

    Bellomo, R., Martensson, J., Lo, S., Kaukonen, KM., Cass, A., & Gallagher, M. (2016). Femoral Access and Delivery of Continuous Renal Replacement Therapy Dose. Blood Purification, 41(1-3), 11-17. https://doi.org/10.1159/000439581